Your browser doesn't support javascript.
loading
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
Malhotra, Jyoti; Nikolinakos, Petros; Leal, Ticiana; Lehman, Jonathan; Morgensztern, Daniel; Patel, Jyoti D; Wrangle, John M; Curigliano, Giuseppe; Greillier, Laurent; Johnson, Melissa L; Ready, Neal; Robinet, Gilles; Lally, Satwant; Maag, David; Valenzuela, Ricardo; Blot, Vincent; Besse, Benjamin.
Afiliação
  • Malhotra J; Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey. Electronic address: jm1940@cinj.rutgers.edu.
  • Nikolinakos P; Hematology and Medical Oncology, University Cancer & Blood Center, Athens, Georgia.
  • Leal T; Hematology-Oncology, Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Lehman J; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Morgensztern D; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Patel JD; Department of Medicine (Oncology), Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Wrangle JM; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Curigliano G; Division of Early Drug Development for Innovative Therapy, Istituto Europeo di Oncologia, IRCCS, Milano, Italy; Department of Oncology and Haematology, University of Milano, Milano, Italy.
  • Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille, Hôpital de la Timone, Aix Marseille University, Marseille, France.
  • Johnson ML; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, Tennessee.
  • Ready N; Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Robinet G; Service de Pneumologie, CHU de Brest-Hôpital Morvan, Brest, France.
  • Lally S; AbbVie Stemcentrx, South San Francisco, California.
  • Maag D; AbbVie Inc., Chicago, Illinois.
  • Valenzuela R; AbbVie Stemcentrx, South San Francisco, California.
  • Blot V; AbbVie Inc., Chicago, Illinois.
  • Besse B; Gustave Roussy, Villejuif, France; Espace Technologique, Paris-Saclay University, Saint-Aubin, France.
J Thorac Oncol ; 16(9): 1559-1569, 2021 09.
Article em En | MEDLINE | ID: mdl-33652156
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article